Unlocking the recovery of dynamic range of focus with microporation therapeutics
Laser Scleral Microporation (LSM) is a therapy which represents the first biomechanical solution to the biomechanical problems of progressive presbyopia. The therapy is performed using the VisioLite® Ophthalmic Laser system developed by Ace Vision Group (AVG).
Today, having no biomechanical option able to meet the loss of dynamic range of focus (DRoF) that occurs with progressive presbyopia, the need remains unmet. Current solutions involve the exchange of refractive power either at the cornea or the lens with the newest solution being a variety of pharmacological miotic eye drops that artificially stimulate the iris muscle to create a “pinhole effect” to see more clearly at near.
Explore More Articles
Ace Vision Group Names David Lin, MD, as Chief Medical Advisor
Dr. Lin’s pioneering expertise in refractive lasers, algorithms and the medical device industry will help drive Ace Vision Group’s device development. BOSTON, Oct. 18, 2024 /PRNewswire/ — Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering rejuvenation therapy for the aging eye, today announced the appointment of David Lin, MD as Chief Medical Advisor (CMA). Dr. Lin …
read moreInsights from Industry Innovators
Carey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast. Topics included touchless laser therapy for presbyopia, extending the duration of intravitreal treatments, next-generation tear fluid testing, and new imaging methodologies for vitreoretinal conditions. Guests include: 🔹Alex Lopez, …
read more